Sands Capital Life Sciences Pulse Fund II, L.P.

10% Owner

Latest Insider Transactions

1 transactions (past 365 days)

IKT
10% Owner
Purchase
$3M
2,068,965 shares @ $1.45
Filed 2025-11-24Trade 2025-11-21
Inhibikase Therapeutics, Inc.